BU Amyloidosis Center receives grant to develop new amyloid diagnostics
The Amyloidosis Center has been awarded a $250,000 grant from the Improving Diagnosis of AL Amyloidosis (IDEA) QuickFire Challenge, run by the pharmaceutical company Johnson & Johnson (J&J) innovation/JLabs. The research, led by Dr. Gareth Morgan, will develop new approaches to identify individuals at risk of AL amyloidosis, and also to help distinguish AL amyloidosis […]
Congratulations to Dr. Andrea Havasi on her recent promotion to Associate Professor of Medicine.
Andrea Havasi, BUSM, Nephrology, specializes in the kidney complications of amyloidosis. Her earliest post-doctoral studies focused on ischemic renal tubular cell injury that led to subsequent studies on the harmful effects of proteinuria on renal tubular function and her current research on the toxic effects of immunoglobulin light-chains in patients with AL amyloidosis. While undertaking […]
Congratulations to our director, Dr. Vaishali Sanchorawala
Congratulations to our director, Dr. Vaishali Sanchorawala, who has been selected for membership to the BUMG Clinical Excellence Society. The BUMG Clinical Excellence Society was established in 2017 to recognize the highest level of clinical excellence. Dr. Sanchorawala was selected for this honor as she attained finalist status in the Excellence in Leadership award category. […]
Dr. John Berk the Assistant Director of the Amyloidosis Center
John Berk, MD, Assistant Director of the center, specializes in familial transthyretin and lung amyloidosis. Dr. Berk designed and conducted the first international randomized controlled trial for familial amyloid polyneuropathy. This NIH- and FDA-funded study found that Diflunisal, an obsolete non-steroidal anti-inflammatory drug, inhibited neurologic disease progression, validated a neurologic metric to map disease progression, […]
U.S. Senate Committee on Appropriations: Amyloidosis Language
HOUSE APPROPRIATIONS COMMITTEE FISCAL YEAR 2022 LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION AMYLOIDOSIS REPORT LANGUAGE H. Rpt. 117-96 (accompany H.R. 4502) July 19, 2021 TITLE II—DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH OFFICE OF THE DIRECTOR (OD) Amyloidosis.—The Committee directs NIH to continue its expansion of research efforts in amyloidosis, a […]
First Virtual Workshop by the International Society of Amyloidosis titled “Structure and Working Modalities of Amyloidosis Centers”
View the videos from the first virtual International Society of Amyloidosis Conference from June 24, 2021. Click this Link to view the videos discussing the Structure and Working Modalities of Amyloidosis centers
Earn CME and CNE by learning about ATTR amyloidosis from this online activity, with Dr. V Sanchorawala, Dr. F Ruberg, and L Mendelson, NP
Provided by Boston University School of Medicine Join our physicians in this patient-centered curriculum. Release Date: 1/29/21 Expiration Date: 1/28/22 Credit Types: CME, CNE, MOC Number of credits: 1.5 Estimated time to complete: 90 minutes
Congratulations to Dr. Gareth Morgan for receiving the Karin Grunebaum Faculty Research Fellowship award.
Join the Amyloidosis Center in congratulating Dr. Gareth, continue with your tremendous work in research.
Structure and Working Modalities of Amyloidosis Centers: ISA Virtual Workshops
ISA Virtual Workshop June 24, 2021 9 AM EDT to 11:00 AM EDT Free, registration required
ACC CardiaCast: Understanding AL and ATTR Cardiac Amyloidosis
In this Podcast, Frederick Ruberg, MD, and Mathew Maurer, MD, discuss key topics in cardiac amyloidosis such as the evolving understanding of the epidemiology of the disease, contemporary approaches to diagnosis with an emphasis on non-invasive means, disease course, and management of heart failure and conduction disease. Click this link to listen to Podcast.